Bank Julius Baer & Co. Ltd Zurich Purchases New Shares in Nutrien Ltd. (NYSE:NTR)

Bank Julius Baer & Co. Ltd Zurich acquired a new position in Nutrien Ltd. (NYSE:NTRFree Report) in the fourth quarter, Holdings Channel reports. The institutional investor acquired 2,832 shares of the company’s stock, valued at approximately $127,000.

A number of other large investors have also recently made changes to their positions in NTR. Healthcare of Ontario Pension Plan Trust Fund purchased a new position in Nutrien in the third quarter worth about $150,181,000. ARGA Investment Management LP lifted its stake in shares of Nutrien by 25.7% in the 4th quarter. ARGA Investment Management LP now owns 6,043,590 shares of the company’s stock valued at $270,396,000 after purchasing an additional 1,236,671 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its holdings in shares of Nutrien by 78.8% in the 3rd quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,495,282 shares of the company’s stock worth $121,271,000 after purchasing an additional 1,100,000 shares during the period. Silchester International Investors LLP increased its position in shares of Nutrien by 9.5% during the 4th quarter. Silchester International Investors LLP now owns 11,693,137 shares of the company’s stock valued at $523,268,000 after purchasing an additional 1,009,895 shares during the last quarter. Finally, Pacific Heights Asset Management LLC raised its holdings in Nutrien by 462.1% during the 4th quarter. Pacific Heights Asset Management LLC now owns 815,000 shares of the company’s stock valued at $36,471,000 after buying an additional 670,000 shares during the period. 63.10% of the stock is currently owned by institutional investors.

Nutrien Price Performance

NTR opened at $51.19 on Wednesday. The company has a market capitalization of $25.05 billion, a price-to-earnings ratio of 37.37, a PEG ratio of 1.19 and a beta of 0.81. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. Nutrien Ltd. has a 12-month low of $43.70 and a 12-month high of $60.87. The business’s fifty day simple moving average is $50.96 and its 200-day simple moving average is $48.63.

Nutrien (NYSE:NTRGet Free Report) last issued its earnings results on Wednesday, February 19th. The company reported $0.28 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.09). Nutrien had a return on equity of 6.81% and a net margin of 2.62%. The business had revenue of $5.08 billion for the quarter, compared to the consensus estimate of $5.09 billion. On average, equities research analysts anticipate that Nutrien Ltd. will post 3.72 earnings per share for the current fiscal year.

Nutrien Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 10th. Investors of record on Monday, March 31st will be issued a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 4.26%. The ex-dividend date is Monday, March 31st. Nutrien’s payout ratio is 159.12%.

Analysts Set New Price Targets

Several research analysts have commented on NTR shares. Piper Sandler lifted their price objective on shares of Nutrien from $58.00 to $63.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. TD Securities dropped their price target on shares of Nutrien from $63.00 to $61.00 and set a “buy” rating for the company in a research note on Tuesday, November 12th. Mizuho upped their price target on shares of Nutrien from $52.00 to $55.00 and gave the company a “neutral” rating in a report on Thursday, February 20th. UBS Group raised their price objective on shares of Nutrien from $53.00 to $54.00 and gave the stock a “neutral” rating in a research note on Thursday, February 20th. Finally, Raymond James raised Nutrien from a “market perform” rating to an “outperform” rating and upped their target price for the company from $58.00 to $60.00 in a research note on Tuesday, December 3rd. One research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, Nutrien has an average rating of “Moderate Buy” and an average target price of $60.13.

Check Out Our Latest Research Report on NTR

Nutrien Company Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Read More

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.